Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition. - Hurcombe JA; Barrington F; Marchetti M; Betin VMS; Bowen EE; Lay AC; Ni L; Dayalan L; Pope RJP; Brinkkoetter PT; Holzenberger M; Welsh GI; et al. (IScience, 2024)